Valrubicin

Overview
Valrubicin (N-trifluoroacetyladriamycin-14-valerate, Valstar®) is a chemotherapy drug used to treat bladder cancer. Valrubicin is a semisynthetic analog of the anthracycline doxorubicin, and is administered by infusion directly into the bladder.

Dosage
800 mg weekly for 6 weeks

Side effects

 * Blood in urine
 * Incontinence
 * painful or difficult urination
 * Unusually frequent urination